Canada’s Medicago announced the successful production of a Virus-Like Particle (VLP) of the coronavirus just 20 days after obtaining the SARS-CoV-2 gene. The company is focused on developing a vaccine for COVID-19, the virus caused by SARS-CoV-2.

Could an arthritis medication show promise as a treatment for the symptoms related to the coronavirus? That’s what Regeneron and Sanofi intend to find out.

Biogen instructed company staff to work from home following additional employees testing positive for the coronavirus. According to reports, 15 employees who attended a management meeting in Boston tested positive for the virus.

A global coalition set up to fight epidemic diseases issued a call for $2 billion to support the development of a vaccine against the new coronavirus that is causing COVID-19 infections around the world.

The U.S. death toll from coronavirus infections rose as new cases emerged around New York City and Los Angeles, while Seattle-area health officials discouraged social gatherings amid the nation’s largest outbreak.

The U.S. House of Representatives overwhelmingly approved an $8.3 billion bill to combat the spread of the new coronavirus and develop vaccines for the highly contagious disease, sending it to the Senate for final passage.

Thermo Fisher

Waltham, Massachusetts-based Thermo Fisher Scientific is acquiring Qiagen N.V., based in Venlo, The Netherlands. Thermo Fisher is offering 39 euros per share in cash for a transaction total of about $11.5 billion, and is also taking on $1.4 billion of net debt.

The Trump administration secured commitments from top pharmaceutical companies to work together to develop a vaccine and treatments to fight the coronavirus.

Cambridge, Massachusetts-based Moderna shipped the company’s first batch of mRNA-1273, a vaccine against the coronavirus, for a planned Phase I clinical trial in the U.S.

U.S. President Donald Trump will seek $2.5 billion from Congress to fight the coronavirus epidemic, and U.S. and South Korean militaries are considering scaling back joint training as the virus spreads in Europe and the Middle East.